Your patients may experience issues during or after infusion with SCIg therapy. Consider these clinical management troubleshooting techniques to possibly help resolve issues that may arise.1
CSL Behring is committed to partnering with you, providing a variety of support services for you and your patients. Explore these links for more information.
Ask a CSL Infusion Science Specialist Nurse for insight, information, and training regarding administration of Hizentra. Take advantage of this service, which is available exclusively for healthcare professionals.
Register for help from an Infusion Science Specialist NurseProper self-infusion training from the start can help patients avoid issues going forward.
Helpful resources include:
Hizentra ConnectSM is a comprehensive resource center to help you and your patients.
Exclusive resources include:
Optimize patient care with nurse education and training on SCIg administration through the SHARE Nurse Training Center.
SHARE nurse trainingMore information about helping patients get started on Hizentra may be found in our FAQ section.
Frequently asked questionsReferences: 1. Murphy E, Burton J, Riley P. Nursing approaches to a novel subcutaneous immunoglobulin therapy. Infusion. 2007;13:1-8. 2. Younger ME, Aro L, Blouin W, et al. Nursing Guidelines for Administration of Immunoglobulin Replacement Therapy. J Infusion Nursing. 2013;36(1):58-68.